down arrow

Shanghai Henlius Biotech, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003N76
HKD
64.80
0.1 (0.15%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
6,206.58
5,961.36
3,738.34
2,027.73
660.27
103.11
8.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,206.58
5,961.36
3,738.34
2,027.73
660.27
103.11
8.79
Raw Material Cost
1,731.39
1,703.66
1,091.57
735.08
253.34
133.19
56.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,795.66
1,797.43
1,570.53
1,052.68
476.76
381.21
245.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
133.24
122.15
122.88
102.23
49.11
54.78
68.58
Selling and Distribution Expenses
2,475.80
2,396.03
1,633.81
965.42
490.24
219.46
119.96
Other Expenses
-86.85
-75.59
-18.11
-2.59
43.02
20.15
7.82
Total Expenditure (Excl Depreciation)
5,267.59
5,263.33
4,237.65
2,829.50
1,699.63
990.12
568.34
Operating Profit (PBDIT) excl Other Income
939
698
-499.3
-801.8000000000001
-1039.4
-887
-559.5
Other Income
111.36
76.98
46.88
-248.89
-24.18
-29.26
35.63
Operating Profit (PBDIT)
1,456.73
1,171.96
-129.61
-809.40
-910.97
-822.73
-473.02
Interest
133.24
122.15
122.88
102.23
49.11
54.78
68.58
Exceptional Items
0.00
-23.48
-231.59
-0.19
-3.78
-20.91
0.00
Gross Profit (PBDT)
4,475.19
4,257.71
2,646.77
1,292.65
406.93
-30.08
-47.42
Depreciation
406.37
396.95
322.82
241.25
152.57
93.55
50.89
Profit Before Tax
917.12
629.38
-806.91
-1,153.07
-1,116.44
-991.96
-592.49
Tax
27.55
26.03
1.60
32.92
0.00
0.74
5.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
889.57
603.35
-808.50
-1,185.99
-1,116.44
-992.70
-584.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
889.57
603.35
-808.50
-1,185.99
-1,116.44
-992.70
-584.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-13.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
889.57
603.35
-808.50
-1,185.99
-1,116.44
-992.70
-597.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
1.19
1.12
1.14
Reserves
3,207.13
2,413.74
1,837.17
2,809.54
3,792.59
4,474.85
2,055.55
Earnings per share (EPS)
1.64
1.1
-1.49
-2.2
-2.11
-2.0
-1.12
Diluted Earnings per share
1.64
1.1
-1.49
-2.2
-2.11
-2.0
-1.12
Operating Profit Margin (Excl OI)
15.13%
11.71%
-13.36%
-39.54%
-157.42%
-860.3%
-6365.84%
Gross Profit Margin
21.32%
17.22%
-12.95%
-44.97%
-145.98%
-871.35%
-6161.6%
PAT Margin
14.33%
10.12%
-21.63%
-58.49%
-169.09%
-962.8%
-6652.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 4.11% vs 59.47% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 47.46% vs 174.62% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 22.87% vs 720.40% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 9.09% vs -0.65% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai Henlius Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
6,206.58
12.21
6,194.37
50,731.94%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,206.58
12.21
6,194.37
50,731.94%
Raw Material Cost
1,731.39
60.54
1,670.85
2,759.91%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,795.66
127.71
1,667.95
1,306.04%
Power Cost
0
0
0.00
Manufacturing Expenses
133.24
14.40
118.84
825.28%
Selling and Distribution Expenses
2,475.80
81.83
2,393.97
2,925.54%
Other Expenses
-86.85
2.09
-88.94
-4,255.50%
Total Expenditure (Excl Depreciation)
5,267.59
305.38
4,962.21
1,624.93%
Operating Profit (PBDIT) excl Other Income
939.00
-293.17
1,232.17
420.29%
Other Income
111.36
3.54
107.82
3,045.76%
Operating Profit (PBDIT)
1,456.73
-232.76
1,689.49
725.85%
Interest
133.24
14.40
118.84
825.28%
Exceptional Items
0.00
-11.01
11.01
100.00%
Gross Profit (PBDT)
4,475.19
-48.33
4,523.52
9,359.65%
Depreciation
406.37
56.88
349.49
614.43%
Profit Before Tax
917.12
-315.05
1,232.17
391.10%
Tax
27.55
-0.27
27.82
10,303.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
889.57
-314.74
1,204.31
382.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
889.57
-314.74
1,204.31
382.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
889.57
-314.74
1,204.31
382.64%
Equity Capital
0
0
0.00
Face Value
1.06
0.00
0.00
Reserves
3,207.13
799.90
2,407.23
300.94%
Earnings per share (EPS)
1.64
-0.78
2.42
310.26%
Diluted Earnings per share
1.64
-0.78
2.42
310.26%
Operating Profit Margin (Excl OI)
15.13%
-2,401.17%
0.00
2,416.30%
Gross Profit Margin
21.32%
-2,114.50%
0.00
2,135.82%
PAT Margin
14.33%
-2,577.85%
0.00
2,592.18%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 620.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.11% vs 59.47% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 88.96 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 47.46% vs 174.62% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 134.54 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.87% vs 720.40% in Dec 2023

Annual - Interest
Interest 13.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 9.09% vs -0.65% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.13%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."